{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:15:10Z","timestamp":1774908910545,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.eprac.2022.07.006","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T02:41:45Z","timestamp":1658371305000},"page":"1100-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-1271","authenticated-orcid":false,"given":"Elena Chertok","family":"Shacham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avraham","family":"Ishay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.eprac.2022.07.006_bib1","first-page":"CD007720","article-title":"Corticosteroids for pneumonia","volume":"12","author":"Stern","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"20","key":"10.1016\/j.eprac.2022.07.006_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"Dexamethasone in adults with bacterial meningitis","volume":"347","author":"De Gans","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib5","first-page":"1","article-title":"Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis","volume":"8","author":"Zayed","year":"2020","journal-title":"J\u00a0Intensive Care"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"Van Paassen","year":"2020","journal-title":"Crit Care"},{"issue":"13","key":"10.1016\/j.eprac.2022.07.006_bib7","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tim.2020.12.007","article-title":"Dysregulation of cell signaling by SARS-CoV-2","volume":"29","author":"Suryawanshi","year":"2021","journal-title":"Trends Microbiol"},{"issue":"13","key":"10.1016\/j.eprac.2022.07.006_bib10","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.3390\/ijms22136764","article-title":"Dexamethasone for severe COVID-19: how does it work at cellular and molecular levels?","volume":"22","author":"Kino","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.006_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"26","key":"10.1016\/j.eprac.2022.07.006_bib13","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02930-2021","article-title":"High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)","volume":"59","author":"Dhooria","year":"2022","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib15","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1210\/jc.2005-0354","article-title":"Cortisol response in relation to the severity of stress and illness","volume":"90","author":"Widmer","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.006_bib16","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/clinem\/dgaa133","article-title":"Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery","volume":"105","author":"Prete","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.eprac.2022.07.006_bib17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness","volume":"368","author":"Boonen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","article-title":"Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction","volume":"1261","author":"Silverman","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/CCM.0000000000002840","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"46","author":"Pastores","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib20","first-page":"1","article-title":"Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS","volume":"6","author":"Meduri","year":"2018","journal-title":"J\u00a0Intensive Care"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib21","first-page":"137","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"33","author":"Annane","year":"2021","journal-title":"Emergencias"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.eprac.2020.10.014","article-title":"The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis","volume":"27","author":"Alzahrani","year":"2021","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2213-8587(20)30216-3","article-title":"Association between high serum total cortisol concentrations and mortality from COVID-19","volume":"8","author":"Tan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib24","first-page":"51","article-title":"Primary adrenal insufficiency after COVID-19 infection","volume":"8","author":"Sanchez","year":"2022","journal-title":"AACE Clin Case Rep"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237690","article-title":"New onset adrenal insufficiency in a patient with COVID-19","volume":"14","author":"Hashim","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1210\/en.2012-2045","article-title":"New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation","volume":"154","author":"Vandevyver","year":"2013","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.006_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fimmu.2019.00938","article-title":"Annexin-A1: therapeutic potential in microvascular disease","volume":"10","author":"Purvis","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.006_bib28","first-page":"2377","article-title":"Therapeutic potential of annexins in sepsis and COVID-19","volume":"12","author":"Mui","year":"2021","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.bjp.0707512","article-title":"Endogenous glucocorticoids control neutrophil mobilization from bone marrow to blood and tissues in non-inflammatory conditions","volume":"152","author":"Cavalcanti","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1067\/mai.2001.116575","article-title":"Glucocorticoids induce basophil apoptosis","volume":"108","author":"Yoshimura","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.eprac.2022.07.006_bib31","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.147.10.3490","article-title":"Glucocorticoids inhibit cytokine-mediated eosinophil survival","volume":"147","author":"Wallen","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib32","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3389\/fimmu.2019.02028","article-title":"More than suppression: glucocorticoid action on monocytes and macrophages","volume":"10","author":"Ehrchen","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","article-title":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes","volume":"109","author":"Ehrchen","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2567.2007.02611.x","article-title":"Glucocorticoids exert opposing effects on macrophage function dependent on their concentration","volume":"122","author":"Lim","year":"2007","journal-title":"Immunology"},{"issue":"18","key":"10.1016\/j.eprac.2022.07.006_bib35","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/emboj.2008.160","article-title":"Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function","volume":"27","author":"Szatmari","year":"2008","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cellimm.2014.05.013","article-title":"Glucocorticoids regulate natural killer cell function epigenetically","volume":"290","author":"Eddy","year":"2014","journal-title":"Cell Immunol"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.006_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41423-020-0477-9","article-title":"Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine","volume":"17","author":"Capellino","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.006_bib38","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/ijms20051142","article-title":"Context-dependent effect of glucocorticoids on the proliferation, differentiation, and apoptosis of regulatory T cells: a review of the empirical evidence and clinical applications","volume":"20","author":"Cari","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1084\/jem.20180595","article-title":"Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses","volume":"216","author":"Franco","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib40","first-page":"1","article-title":"Genomic and non-genomic effects of glucocorticoids: implications for breast cancer","volume":"8","author":"Mitre-Aguilar","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"10.1016\/j.eprac.2022.07.006_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000342502","article-title":"Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance","volume":"24","author":"Ramamoorthy","year":"2013","journal-title":"Endocr Dev"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"9203","key":"10.1016\/j.eprac.2022.07.006_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","article-title":"Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment","volume":"355","author":"Henzen","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1113\/jphysiol.2002.028183","article-title":"Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium","volume":"545","author":"Urbach","year":"2002","journal-title":"J\u00a0Physiol (Lond)"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.006_bib46","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing\u2019s syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.006_bib47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11154-020-09598-x","article-title":"Glucocorticoid excess and COVID-19 disease","volume":"22","author":"Guarnotta","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12020-021-02674-5","article-title":"Clinical course and outcome of patients with ACTH-dependent Cushing\u2019s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations","volume":"72","author":"Belaya","year":"2021","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.006_bib49","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fendo.2020.00554","article-title":"Practical considerations for the management of Cushing\u2019s disease and COVID-19: a case report","volume":"11","author":"Beretta","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.006_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1507\/endocrj.EJ20-0613","article-title":"Successful management of a patient with active Cushing\u2019s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia","volume":"68","author":"Yuno","year":"2021","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.eprac.2022.07.006_bib51","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s40618-020-01419-x","article-title":"COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy","volume":"44","author":"Serban","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.eprac.2022.07.006_bib52","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cells10040897","article-title":"The role of macrophages in the development of acute and chronic inflammatory lung diseases","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.eprac.2022.07.006_bib53","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids","volume":"16","author":"Brereton","year":"2020","journal-title":"Breathe (Sheff)"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-017-1723-0","article-title":"The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study","volume":"21","author":"Takaki","year":"2017","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-018-0597-5","article-title":"The relationship between high-dose corticosteroid treatment and mortality in acute respiratory distress syndrome: a retrospective and observational study using a nationwide administrative database in Japan","volume":"18","author":"Kido","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"11","key":"10.1016\/j.eprac.2022.07.006_bib56","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: a meta-analysis","volume":"92","author":"Aziz","year":"2020","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jmv.26085","article-title":"Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis","volume":"93","author":"Zhu","year":"2021","journal-title":"J\u00a0Med Virol"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2022.07.006_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with Covid-19 pneumonia","volume":"385","author":"Guimaraes","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.006_bib61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00508-020-01805-8","article-title":"Methylprednisolone in adults hospitalized with COVID-19 pneumonia: an open-label randomized trial (GLUCOCOVID)","volume":"133","author":"Corral-Gudino","year":"2021","journal-title":"Wien Klin Wochenschr"},{"issue":"13","key":"10.1016\/j.eprac.2022.07.006_bib62","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib63","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-021-01833-6","article-title":"The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial","volume":"22","author":"Ghanei","year":"2021","journal-title":"Respir Res"},{"issue":"12","key":"10.1016\/j.eprac.2022.07.006_bib66","article-title":"NF-\u03baB pathway as a potential target for treatment of critical stage COVID-19 patients","volume":"11","author":"Kircheis","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","article-title":"The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients","volume":"29","author":"Hariharan","year":"2021","journal-title":"Inflammopharmacology"},{"issue":"1-2","key":"10.1016\/j.eprac.2022.07.006_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"10.1016\/j.eprac.2022.07.006_bib69","first-page":"592","article-title":"Endothelial response to glucocorticoids in inflammatory diseases","volume":"7","author":"Zielinska","year":"2016","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.eprac.2022.07.006_bib70","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.2147\/JIR.S330356","article-title":"Elevated serum levels of progranulin and soluble vascular cell adhesion molecule-1 in patients with COVID-19","volume":"14","author":"Yao","year":"2021","journal-title":"J\u00a0Inflamm Res"},{"issue":"8","key":"10.1016\/j.eprac.2022.07.006_bib71","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/infdis\/jiab042","article-title":"Role of cell adhesion molecules for prognosis of disease development of patients with and without COVID-19 in the emergency department","volume":"223","author":"Bauer","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.eprac.2022.07.006_bib72","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2019.01591","article-title":"Glucocorticoids shape macrophage phenotype for tissue repair","volume":"10","author":"Desgeorges","year":"2019","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.eprac.2022.07.006_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cytogfr.2016.05.002","article-title":"A gradient of glucocorticoid sensitivity among helper T cell cytokines","volume":"31","author":"Banuelos","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib74","first-page":"1","article-title":"Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19","volume":"6","author":"Lu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"10.1016\/j.eprac.2022.07.006_bib75","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 receptor inhibition in Covid-19\u2014cooling the inflammatory soup","volume":"384","author":"Rubin","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.07.006_bib76","doi-asserted-by":"crossref","first-page":"JC2","DOI":"10.7326\/ACPJ202101190-002","article-title":"WHO recommends corticosteroids for patients with severe or critical COVID-19","volume":"174","author":"Keyt","year":"2021","journal-title":"Ann Intern Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22005651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22005651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:35Z","timestamp":1761516755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22005651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1530891X22005651"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.07.006","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}